New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 21, 2013
09:05 EDTORCL, ITMN, ACAD, TUMI, GES, MOV, PERY, AZN, YHOO, CSCO, SCHLOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Perry Ellis (PERY), up 5.2%... Movado (MOV), up 2.4%... ALSO HIGHER: InterMune (ITMN), up 12.2% after health technology appraisal body in England and Wales recommends use of its Esbriet drug... ACADIA (ACAD), up 7.5% after presenting detailed results from a Phase III study of its treatment for Parkinson's disease psychosis... AstraZeneca (AZN), up 2.8% after saying it plans to restructure its SG&A activities to cut out about 2,300 jobs, announcing partnership agreement with Moderna Therapeutics... Yahoo! (YHOO), up 2% following upgrade at Oppenheimer... DOWN AFTER EARNINGS: Oracle (ORCL), down 7.6%... Guess (GES), down 6%... Tumi (TUMI), down 6%... Scholastic (SCHL), down 11.5%... ALSO LOWER: Cisco (CSCO), down 2.5%, following downgrade at FBR Capital... General Moly (GMO), down 21%, after work suspended on a $665M loan being negotiated for the development of its Mt. Hope Project.
News For ORCL;CSCO;YHOO;AZN;PERY;MOV;GES;TUMI;ACAD;ITMN;SCHL From The Last 14 Days
Check below for free stories on ORCL;CSCO;YHOO;AZN;PERY;MOV;GES;TUMI;ACAD;ITMN;SCHL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 25, 2014
06:35 EDTORCLEU poised to decide on Oracle, MICROS agreement, Reuters says
Subscribe for More Information
July 24, 2014
09:36 EDTYHOOActive equity options trading on open
Subscribe for More Information
07:19 EDTSCHLScholastic sees FY15 EPS $1.80-$2.00, consensus $1.98
Subscribe for More Information
07:17 EDTSCHLScholastic reports Q4 adjusted EPS $1.24, one estimate 91c
Subscribe for More Information
05:56 EDTYHOOStocks with implied volatility movement; YHOO GILD
Subscribe for More Information
July 23, 2014
14:58 EDTYHOOYahoo speculated as target for Alibaba, Softbank, Forbes contributor says
Forbes contributor Eric Jackson contends that after he previously published an article which wondered if Yahoo (YHOO) could be a takeover target and after "chatting with a large Yahoo shareholder," he now believes the most likely outcome is that either Alibaba (BABA) or SoftBank (SFTBF) buys Yahoo. Reference Link
July 22, 2014
15:07 EDTCSCOEarnings Preview: Microsoft to report after Nadella makes big job cuts
Subscribe for More Information
10:48 EDTYHOOOptions with decreasing implied volatility
Options with decreasing implied volatility: IGT YHOO LYK ATHN CMG SWKS NFLX SHPG SNDK MTG
08:14 EDTCSCOCisco to establish Global IoE Innovation Center in Barcelona
Cisco and Barcelona City Council announced plans to open a Cisco Global IoE Innovation Center in Barcelona. The Innovation Center will provide a platform for research, technological development and new market opportunities related to the Internet of Everything for smart cities. The new 1,720 SQM Cisco center will be located at Ca l'Alier, a 19th century heritage building at the core of the 22@Barcelona district, as part of the new Smart City Campus. Based on its current plans, from 2015 to 2020, Cisco intends to invest close to $30M in the facilities' restoration, innovation lab, IT equipment, and talent acquisition primarily in engineering, application development and research.
05:56 EDTYHOOYahoo paying over $200M for Flurry, TechCrunch reports
Subscribe for More Information
05:25 EDTAZNAdams Express, MedImmune announce clinical trial partnership
Advaxis (ADXS) has entered into a clinical trial collaboration with MedImmune, the global biologics research and development arm of AstraZeneca (AZN). The Phase I/II immunotherapy study will evaluate the safety and efficacy of MedImmune's investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with Advaxis' lead cancer immunotherapy vaccine, ADXS-HPV, as a treatment for patients with advanced, recurrent or refractory human papillomavirus, or HPV,-associated cervical cancer and HPV-associated head and neck cancer. Both MEDI4736 and ADXS-HPV are cancer immunotherapies, a new class of treatments that use the body's own immune system to help fight cancer. Under the terms of the agreement, MedImmune and Advaxis will evaluate the combination as a treatment for HPV-associated cervical cancer and squamous cell carcinoma of the head and neck. The Phase I part of the trial is expected to establish a recommended dose regimen of MEDI4736 with ADXS-HPV, and the Phase II portion will assess the safety and efficacy of the combination. The study will be funded and conducted by Advaxis. Results from the study will be used to determine whether further clinical development of this combination is warranted. Under the terms of the deal, MedImmune has a non-exclusive relationship with respect to HPV-driven tumour types. MedImmune has first right of negotiation for future development of combinations involving MEDI4736 and ADXS-HPV.
July 21, 2014
16:52 EDTYHOOGoogle ranked as top U.S. search marketplace in June
Subscribe for More Information
16:41 EDTYHOOYahoo to acquire Flurry
Yahoo! and Flurry, Inc. announced that they have reached a definitive agreement for Yahoo to acquire Flurry. Yahoo is on a mission to re-imagine users’ daily habits, and mobile is at the center of everything we do. Our agreement to acquire Flurry is a meaningful step for the company and reinforces Yahoo’s commitment to building and supporting useful, inspiring and beautiful mobile applications and monetization solutions. By joining Yahoo, Flurry will have resources to speed up the delivery of platforms that help developers build better apps, reach the right users, and explore new revenue opportunities. Together, the companies can make mobile experiences better through products that are more personalized and more inspiring. Analytics are critical for all mobile developers to understand and optimize their applications. Yahoo and Flurry are reinvesting in developers and continuing to build great analytics products. The combined scale of the two companies will accelerate revenue growth for thousands of developers and publishers across the mobile ecosystem. In addition, the joined offerings of Yahoo and Flurry will enable more effective mobile advertising solutions for brands seeking to reach their audiences and gain unique insights across desktop and mobile, and users will benefit from more personalized app experiences. Following the closing, the Flurry team will remain in their present locations, and Flurry’s vision, mission, and focus will stay the same. Flurry’s products will continue to operate and innovate with Yahoo’s support and investment. The transaction is subject to customary closing conditions.
14:59 EDTYHOOYahoo to buy mobile and app analytics start-up Flurry, Re/code says
Subscribe for More Information
14:55 EDTYHOOYahoo to buy Flurry for 'hundreds of millions,' Re/code says
Subscribe for More Information
14:11 EDTYHOOYahoo to be exclusive U.S home for pre-theatrical release of 'One Chance'
Yahoo announced in a post to Tumblr, that it will be the exclusive US home for the pre-theatrical release of the Weinstein Company’s film “One Chance.” The company said, "Whether it’s comedy, live events or inspiring stories, we are always looking to bring the very best content from the world’s greatest creators to our audience. That’s why today, we’re thrilled to announce that this fall, we’ll be the exclusive US home for the pre-theatrical release of the Weinstein Company’s film “One Chance.” Reference Link
13:15 EDTYHOOGoogle ranked as top online video content property in June
Subscribe for More Information
11:19 EDTITMNInterMune July weekly volatility elevated
Subscribe for More Information
10:42 EDTYHOOOptions with decreasing implied volatility
Subscribe for More Information
07:15 EDTYHOOO'Reilly to hold a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use